_id_803ca5ef-1be9-4d2b-936b-173127cf62d2_size900.jpg?#)
Bioventix (AIM:BVXP) Stock FY Results Keep Margins Strong Dividend Questions Open
Bioventix entered this full year update on a strong run, with the stock up more than 30% over the past three months and trading at £19.90 at last close. The long term pitch is clear: a high margin antibody specialist with rich cash generation and an income story that attracts yield focused investors. Today’s FY 2026 numbers keep that profitability story in focus. Net profit margin sits close to 59% and basic earnings per share reach about £1.46 over the trailing twelve months. The share price...
Bioventix entered this full year update on a strong run, with the stock up more than 30% over the past three months and trading at £19.90 at last close. The long term pitch is clear: a high margin antibody specialist with rich cash generation and an income story that attracts yield focused investors. Today’s FY 2026 numbers keep that profitability story in focus. Net profit margin sits close to 59% and basic earnings per share reach about £1.46 over the trailing twelve months. The share price...
What's Your Reaction?
